EMEA-000780-PIP01-09-M06
Key facts
| Invented name |
Rydapt
|
| Active substance |
Midostaurin
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0086/2021
|
| PIP number |
EMEA-000780-PIP01-09-M06
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Novartis Europharm Ltd
Tel. +41 61 324 1111 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|